Home / Sweden / Hansa Biopharma AB

Hansa Biopharma AB

Short position disclosed on September 28, 2026. Finansinspektionen register read on November 4, 2026.

Follow

1.60% of the capital sold short
#39 of 96 rank in Sweden
0.00 pt over 5 days
-0.79 pt over 20 days
2 disclosing funds
419 disclosures on record
SE0002148817 ISIN code

Evolution of the disclosed total

Open positions

In the United States HNSBF (OTC): 94,936 shares sold short on October 15, 2026. FINRA names no fund.

On the other side: the funds that hold Hansa Biopharma AB Titelia

History of disclosures

Download 419 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Sweden

• Samhällsbyggnadsbolaget i Norden AB 11.36% of the capital sold short
• JM AB 7.91% of the capital sold short
• Elekta AB (publ) 7.77% of the capital sold short
• Truecaller AB 7.11% of the capital sold short
• Intrum AB 6.21% of the capital sold short
• Mips AB 5.23% of the capital sold short
• RaySearch Laboratories AB (publ) 5.15% of the capital sold short
• Xvivo Perfusion Aktiebolag 5.15% of the capital sold short
• Cibus Real Estate AB (publ) 4.78% of the capital sold short
• Hemnet Group AB (publ) 4.67% of the capital sold short
• Aktiebolaget Electrolux 4.58% of the capital sold short
• Dynavox Group AB 4.31% of the capital sold short